PD27-06: Novel androgen receptor recurring splice junctions in prostate cancer predicts response to abiraterone and overall survival in metastatic prostate cancer.

Monday, May 18, 2026 10:10 AM to 10:18 AM · 8 min. (America/New_York)
206
Abstract

Registered attendees

Kendrick Yim
Kendrick Yim
Clinical FellowMoffitt Cancer Center

Log in

See all the content and easy-to-use features by logging in or registering!